Investors Buy Sanofi (SNY) on Weakness
Traders bought shares of Sanofi (NYSE:SNY) on weakness during trading hours on Monday. $24.87 million flowed into the stock on the tick-up and $6.46 million flowed out of the stock on the tick-down, for a money net flow of $18.41 million into the stock. Of all companies tracked, Sanofi had the 19th highest net in-flow for the day. Sanofi traded down ($0.10) for the day and closed at $41.58
Several equities research analysts recently issued reports on the stock. Zacks Investment Research upgraded shares of Sanofi from a “hold” rating to a “buy” rating and set a $46.00 target price for the company in a research note on Wednesday, May 4th. HSBC downgraded shares of Sanofi from a “buy” rating to a “hold” rating in a research report on Tuesday, May 3rd. Bank of America Corp. restated a “buy” rating and set a $58.00 price objective on shares of Sanofi in a research report on Tuesday, May 3rd. Barclays PLC upgraded shares of Sanofi from an “equal weight” rating to an “overweight” rating in a research report on Thursday, May 12th. Finally, JPMorgan Chase & Co. restated a “sell” rating on shares of Sanofi in a research report on Monday, April 25th. Four investment analysts have rated the stock with a sell rating, six have given a hold rating and four have assigned a buy rating to the company’s stock. Sanofi has an average rating of “Hold” and an average target price of $49.67.
The firm has a market capitalization of $107.15 billion and a P/E ratio of 22.64. The firm’s 50 day moving average price is $40.58 and its 200-day moving average price is $40.68.
A number of large investors have recently modified their holdings of the company. Stephens Inc. AR increased its stake in shares of Sanofi by 4.5% in the fourth quarter. Stephens Inc. AR now owns 56,811 shares of the company’s stock worth $2,423,000 after buying an additional 2,424 shares during the last quarter. Freestone Capital Holdings LLC purchased a new stake in shares of Sanofi during the fourth quarter worth about $1,672,000. Cypress Asset Management Inc. TX increased its stake in shares of Sanofi by 39.2% in the fourth quarter. Cypress Asset Management Inc. TX now owns 75,680 shares of the company’s stock worth $3,228,000 after buying an additional 21,300 shares during the last quarter. Bank of Montreal Can increased its stake in shares of Sanofi by 0.7% in the fourth quarter. Bank of Montreal Can now owns 389,519 shares of the company’s stock worth $16,614,000 after buying an additional 2,560 shares during the last quarter. Finally, Haverford Trust Co. increased its stake in shares of Sanofi by 3.5% in the fourth quarter. Haverford Trust Co. now owns 500,192 shares of the company’s stock worth $21,333,000 after buying an additional 16,855 shares during the last quarter.
Sanofi SA is a healthcare company focused on patient needs and engaged in the research, development, manufacture and marketing of healthcare products. The Company is organized around three principal activities: Pharmaceuticals, Human Vaccines via Sanofi Pasteur, and Animal Health via Merial. The Company invests in emerging markets, diabetes solutions, vaccines, consumer health care, animal health, genzyme and other products.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.